Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Ann Oncol. 2012 Oct:23 Suppl 7:vii124-30. doi: 10.1093/annonc/mds295.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Intestinal Neoplasms / diagnosis*
  • Intestinal Neoplasms / pathology
  • Intestinal Neoplasms / therapy
  • Neoplasm Staging
  • Neoplasms, Hormone-Dependent / diagnosis*
  • Neoplasms, Hormone-Dependent / pathology
  • Neoplasms, Hormone-Dependent / therapy
  • Neuroendocrine Tumors / diagnosis*
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / therapy
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Stomach Neoplasms / diagnosis*
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / therapy
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal

Supplementary concepts

  • Gastro-enteropancreatic neuroendocrine tumor